BASE life science A/S Financials, key figures and credit report
Gross profit 93 921.0 kDKK FY 2024 +0.6% vs 2023
EBIT -39 260.8 kDKK FY 2024 +38.7% vs 2023
Net debt -29 454.0 kDKK FY 2024 -132.5% vs 2023
Quick ratio 1.6 FY 2024 +0.6 vs 2023
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 93 829.70 | 117 471.34 | 84 927.80 | 93 372.44 | 93 920.95 |
| Employee benefit expenses | -76 910.38 | -92 369.85 | - 147 348.71 | - 153 668.59 | - 130 296.13 |
| Total depreciation | - 138.38 | - 903.57 | -2 849.63 | -3 717.12 | -2 885.61 |
| EBIT | 16 780.95 | 24 197.92 | -65 270.54 | -64 013.27 | -39 260.78 |
| Other financial income | 109.67 | 243.35 | 60.43 | 160.64 | 4 839.35 |
| Other financial expenses | - 280.54 | - 447.27 | - 528.25 | -3 556.89 | -4 297.21 |
| Net income from associates (fin.) | 6 435.59 | 34 479.08 | -20 514.63 | -12 096.73 | |
| Pre-tax profit | 16 610.08 | 30 429.59 | -31 259.28 | -87 924.15 | -50 815.38 |
| Income taxes | -2 848.17 | -6 234.79 | 35.00 | 3.04 | 811.50 |
| Net earnings | 13 761.91 | 24 194.81 | -31 224.29 | -87 921.12 | -50 003.88 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 4 123.26 | 4 824.69 | 3 859.75 | 2 894.81 | 1 929.88 |
| Intangible rights | 83.07 | 65.27 | 47.47 | ||
| Intangible assets total | 4 123.26 | 4 824.69 | 3 942.82 | 2 960.08 | 1 977.34 |
| Machinery and equipment | 460.29 | 3 081.77 | 3 907.50 | 2 769.52 | 4 392.62 |
| Tangible assets total | 460.29 | 3 081.77 | 3 907.50 | 2 769.52 | 4 392.62 |
| Holdings in group member companies | 886.24 | 10 596.22 | 44 800.42 | 25 919.15 | 14 469.53 |
| Investments total | 1 355.16 | 11 521.41 | 45 852.23 | 27 185.04 | 16 024.75 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 30 769.99 | 66 635.97 | 43 722.67 | 53 601.02 | 55 463.04 |
| Current amounts owed by group member comp. | 1 520.86 | 8 203.86 | 22 060.93 | 20 491.15 | 26 225.40 |
| Current owed by particip. interest comp. | 172.12 | ||||
| Prepayments and accrued income | 392.25 | 4 062.73 | 2 464.54 | 4 118.87 | 2 348.37 |
| Current other receivables | 8 012.33 | 7 545.74 | 28 400.40 | 32 273.38 | 23 424.26 |
| Current deferred tax assets | 921.39 | 767.00 | |||
| Short term receivables total | 41 616.81 | 86 448.29 | 96 820.65 | 111 251.42 | 107 461.07 |
| Cash and bank deposits | 6 597.92 | 114.27 | 4 123.40 | 11 804.35 | 67 401.43 |
| Cash and cash equivalents | 6 597.92 | 114.27 | 4 123.40 | 11 804.35 | 67 401.43 |
| Balance sheet total (assets) | 54 153.44 | 105 990.43 | 154 646.60 | 155 970.41 | 197 257.21 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 600.00 | 600.00 | 597.40 | 597.40 | 600.40 |
| Share premium account | 164 123.00 | ||||
| Shares repurchased | 2 109.00 | ||||
| Other reserves | 4 123.26 | 13 235.56 | 46 612.54 | 25 345.25 | 11 052.21 |
| Retained earnings | 5 575.18 | 12 184.90 | 5 510.58 | -4 234.13 | -77 649.92 |
| Profit of the financial year | 13 761.91 | 24 194.81 | -31 224.29 | -87 921.12 | -50 003.88 |
| Shareholders equity total | 26 169.35 | 50 215.27 | 21 496.23 | -66 212.60 | 48 121.81 |
| Provisions | 1 250.00 | 1 265.27 | 1 017.99 | 802.66 | 731.91 |
| Non-current loans from credit institutions | 1 923.29 | ||||
| Non-current owed to group member | 97 379.54 | 36 819.54 | |||
| Non-current liabilities total | 1 923.29 | 97 379.54 | 36 819.54 | ||
| Current loans from credit institutions | 110.68 | 3 063.09 | 347.65 | 589.27 | 503.57 |
| Advances received | 256.35 | 947.68 | 2 389.61 | ||
| Current trade creditors | 3 772.80 | 22 052.03 | 62 424.48 | 57 535.18 | 64 681.41 |
| Current owed to participating | 513.06 | 513.06 | |||
| Current owed to group member | 4 037.21 | 4 358.09 | 624.32 | ||
| Short-term deferred tax liabilities | 3 451.76 | 7 938.33 | 2 982.57 | ||
| Other non-interest bearing current liabilities | 16 470.78 | 19 995.72 | 59 950.87 | 61 518.26 | 45 774.65 |
| Accruals and deferred income | 235.36 | ||||
| Current liabilities total | 24 810.80 | 54 509.90 | 132 132.39 | 124 000.81 | 111 583.94 |
| Balance sheet total (liabilities) | 54 153.44 | 105 990.43 | 154 646.60 | 155 970.41 | 197 257.21 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 The current price above includes VAT and is paid securely through Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated